Raymond DuBois, MD, PhD, past-president of the AACR (2008-2009), fellow of the AACR Academy, and chairman and president of...
Levi Garraway, MD, PhD, co-chair of the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics in Boston Nov....
An emerging hallmark of cancer cells is their ability to hide from the body’s immune system. The human immune...
On the heels of the U.S. Food and Drug Administration’s approval of a combination of immune checkpoint inhibitors for...
Government task force drafts recommendations for low-dose aspirin for the prevention of cardiovascular disease and colorectal cancer; a study...
The inaugural International Cancer Immunotherapy Conference, hosted jointly by the Cancer Research Institute (CRI), the Association for Cancer Immunotherapy...
Two studies published today in the AACR's journal Cancer Research describe developing CAR T cells to make them safe...
China, a nation of 1.3 billion people, is facing an ongoing cancer epidemic, with more than 3 million people...
Pediatric oncologist and precision medicine expert Andrew Kung, MD, PhD, of Columbia University explains.
This post explores the challenges we face with anti-EGFR monoclonal antibody therapies and new strategies researchers have developed to...